Coagulation disorders in the ICU.
Disorders of hemostasis and thrombosis are frequently encountered in the ICU setting. Understanding the relevance of laboratory findings is essential in providing appropriate therapy. Various blood products and hemostatic agents are available to assist in the control of bleeding, and several different classes of anticoagulants are now available for use. Appropriate use of these agents maximizes therapeutic effect while minimizing complications. Use of fresh frozen plasma, cryoprecipitate, and other hemostatic agents should generally be reserved for those who have active bleeding, those undergoing invasive procedures, and those at high risk for bleeding because of their underlying diagnoses or because of associated hematologic derangements.
Marks
Peter W
PW
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA. peter.marks@yale.edu
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D001780:Blood Coagulation Tests; D001803:Blood Transfusion; D003422:Critical Care / Q000379:methods*; D003937:Diagnosis, Differential; D006470:Hemorrhage / Q000517:prevention & control; D006487:Hemostasis; D006801:Humans; D007362:Intensive Care Units; D013921:Thrombocytopenia / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D054556:Venous Thromboembolism / Q000517:prevention & control
D000925:Anticoagulants